Relay Therapeutics (RLAY) Interest Coverage Ratio: History & Chart

Relay Therapeutics, Inc.(RLAY)

Biotechnology · Cambridge, MA

$18.74-0.65 (-3.35%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RLY-1971, another oral small molecule, an inhibitor of SHP2 (protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2), currently in Phase 1 trials for individuals with advanced solid tumors. Relay Therapeutics has established strategic partnerships, including a collaboration with D. E. Shaw Research, LLC, which utilizes computational modeling to analyze protein motion for the identification and development of therapeutic compounds. Furthermore, an agreement with Genentech, Inc. supports the development and commercialization of RLY-1971. Founded in 2015 as Allostery, Inc., the company rebranded to Relay Therapeutics, Inc. in December of that year and maintains its headquarters in Cambridge, Massachusetts.

Cambridge, MA

202 employees

www.relaytx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Sanjiv K. Patel

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Relay Therapeutics, Inc. (RLAY)	$4.11B	N/A	N/A	N/A	N/A
LivaNova PLC (LIVN)vs ›	$4.12B	4.05x	3.05x	3.05x	3.05x
AbCellera Biologics Inc. (ABCL)vs ›	$4.02B	N/A	46.33x	38.87x	38.87x
ICU Medical, Inc. (ICUI)vs ›	$3.99B	1.01x	0.71x	0.54x	40.25x
Adaptive Biotechnologies Corporation (ADPT)vs ›	$4.31B	-4.85x	N/A	N/A	N/A
Edgewise Therapeutics, Inc. (EWTX)vs ›	$4.31B	N/A	N/A	N/A	N/A
Heartflow, Inc. Common Stock (HTFL)vs ›	$4.37B	-4.22x	N/A	N/A	N/A
Indivior Pharmaceuticals Inc (INDV)vs ›	$4.48B	5.89x	3.33x	3.33x	4.95x
Regencell Bioscience Holdings Limited (RGC)vs ›	$3.64B	N/A	N/A	N/A	N/A
BillionToOne, Inc. (BLLN)vs ›	$4.60B	168.66x	168.66x	168.66x	168.66x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Relay Therapeutics, Inc. (RLAY)

$4.11B

N/A

LivaNova PLC (LIVN)vs ›

$4.12B

4.05x

3.05x

AbCellera Biologics Inc. (ABCL)vs ›